CurrentCardio
Get Weekly

Topic · page 5 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 161–200 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Eur J Heart Fail

    The C-MIC II follow-up study: safety and efficacy results 12 months after deactivation of cardiac microcurrent therapy

    Cohort study

  2. Heart

    Weight loss as a marker of successful decongestion during acute heart failure hospitalisation

    Cohort study

  3. Circulation

    International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy

    Cohort study

  4. Eur Heart J Cardiovasc Pharmacother

    Clinical and experimental insights into hydroxychloroquine-associated electrical abnormalities and cardiomyopathy

    Research article

  5. Am Heart J

    Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: An integrated analysis of phase 3 clinical trials

    Research article

  6. JACC Adv

    Artificial Intelligence-Enabled Electrocardiograms and Pregnancy-Related Cardiomyopathy: A Systematic Review and Diagnostic Meta-Analysis

    Meta-analysis

  7. Eur J Prev Cardiol

    Undetected Heart Failure in Cardiology: Prevalence, Characteristics, and Outcome

    Cohort study

  8. JACC Clin Electrophysiol

    Direct His/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB: The His-Alternative II Study

    Randomised controlled trial

  9. J Am Coll Cardiol

    Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023

    Research article

  10. JACC Adv

    A National Survey of VA to Assess Availability of Care for Patients With Cardiac Amyloidosis

    Cross-sectional study

  11. Heart

    Prognostic and exploratory neurohormonal correlates of hypochloraemia in heart failure: a multicentre cohort study

    Cohort study

  12. ESC Heart Fail

    Characterizing clinically recognized hypertrophic cardiomyopathy in six European countries using real-world data

    Cohort study

  13. ESC Heart Fail

    Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation

    Cohort study

  14. Eur Heart J

    Heart transplantation allograft survival: donor atherosclerotic disease risk vs coronary angiography

    Cohort study

  15. ESC Heart Fail

    Timing-specific factors associated with early, intermediate, and late readmission after heart failure hospitalization

    Secondary analysis

  16. JAMA Cardiol

    Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial

    Secondary analysis

  17. Nat Med

    Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial

    Randomised controlled trial

  18. JACC Adv

    Neighborhood Socioeconomic Status and Heart Failure or All-Cause Readmission Within a Municipal Hospital System

    Cohort study

  19. ESC Heart Fail

    Ambulatory low cardiac output state in heart failure: characteristics and outcomes

    Research article

  20. Eur J Heart Fail

    Iron deficiency and bone metabolism in heart failure

    Cross-sectional study

  21. ESC Heart Fail

    Parity and heart failure risk in diabetic women with coronary artery disease: a multicentre cohort study

    Cohort study

  22. Eur J Heart Fail

    Persistent atrial myopathy despite ventricular recovery: prognostic significance of discordant LV–LA strain patterns in HFrEF

    Cohort study

  23. Eur J Heart Fail

    Strategies for preventing and reversing atrial cardiomyopathy: current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement

    Guideline or statement

  24. Eur Heart J Qual Care Clin Outcomes

    Deterministic Economic Modelling Study of Tafamidis in Transthyretin Amyloid Cardiomyopathy Across Four European Healthcare Systems

    Research article

  25. ESC Heart Fail

    Differential Rates of Guideline-Directed Medical Therapy Modification in C-MIC and Control Patients: Results from the C-MIC II Trial

    Secondary analysis

  26. JACC Heart Fail

    Effect of Sacubitril/Valsartan on Functional and Structural Cardiac Parameters in Adults With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Controlled Trial

    Randomised controlled trial

  27. Circ Popul Health Outcomes

    Effect Modification of Remote Patient Management by Sex and Marital Status Among Patients With Heart Failure in Germany: Findings From the Extended Interdisciplinary Network Heart Failure Trial

    Secondary analysis

  28. Eur J Heart Fail

    Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction

    Secondary analysis

  29. JACC Adv

    INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy

    Research article

  30. Am Heart J

    Cardiac allograft vasculopathy and secondary outcomes at 1-year in heart transplantation from circulatory death donors

    Cohort study

  31. Heart Rhythm

    Heart failure risk stratification at the time of implantable cardioverter-defibrillator implantation after myocardial infarction: The HF WICD-MI score

    Diagnostic or prognostic study

  32. Circ Popul Health Outcomes

    Shifting From Event Rates to Time at Home After Hospitalization for Heart Failure With Reduced Ejection Fraction: Trends and Equity in Days Alive and Out of Hospital in Singapore

    Cohort study

  33. JACC Adv

    Prognostic Value of New Proposed Criteria for Atrial Cardiomyopathy in Patients With Heart Failure

    Cohort study

  34. Eur Heart J Cardiovasc Imaging

    Cardiovascular magnetic resonance reveals stable myocardial tissue characteristics despite cardiac remodelling after transjugular intrahepatic portosystemic shunt in liver cirrhosis

    Cohort study

  35. Europace

    Conduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis considering randomized controlled trials and observational studies

    Meta-analysis

  36. Europace

    Conduction system vs. biventricular pacing in heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials

    Meta-analysis

  37. Eur Heart J Qual Care Clin Outcomes

    Development and external validation of an AI-ECG algorithm for estimating elevated serum NT-proBNP levels

    Diagnostic or prognostic study

  38. JAMA Cardiol

    Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI

    Secondary analysis

  39. ESC Heart Fail

    Lower limb compression in acute heart failure and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial

    Trial design

  40. Heart Rhythm

    Clinical characteristics and prognostic impact of multiple pathogenic variants across the genetic spectrum of arrhythmogenic and dilated cardiomyopathies

    Research article

All 1,928 Briefs in ExploreShowing Briefs 161–200 of 1,928, newest first